CeriBell, Inc.(CBLL) - 2024 Q3 - Quarterly Results

Ceribell Reports Third Quarter 2024 Financial Results Sunnyvale, CA – November 12, 2024 – CeriBell, Inc. (Nasdaq: CBLL) ("Ceribell"), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today reported financial results for the quarter ended September 30, 2024. Third Quarter 2024 & Recent Highlights • Reported total revenue of $17.2 million in the third quarter of 2024, a 48% increase compared to the same period in 2023 • Achieve ...